The Role of Minocycline in Neuro-Cognitive Symptoms in the Episodes of Primary Psychosis: A Clinical Trial
This study was conducted to compare the neurocognitive changes in an episode of primary psychosis in a group treated with minocycline and control. In this randomized controlled clinical trial, 40 patients with schizophrenia were randomized into two groups and underwent eight weeks of treatment with...
Main Authors: | Abolfazl Ghoreishi, Saeed Granpy, Alireza Armani |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2020-08-01
|
Series: | Acta Medica Iranica |
Subjects: | |
Online Access: | https://acta.tums.ac.ir/index.php/acta/article/view/8203 |
Similar Items
-
Minocycline as adjunct therapy for a male patient with deficit schizophrenia
by: Chen X, et al.
Published: (2018-10-01) -
Cerebellar Structural Abnormalities Associated With Cognitive Function in Patients With First-Episode Psychosis
by: Taekwan Kim, et al.
Published: (2018-07-01) -
Minocycline for negative symptoms of schizophrenia and possible mechanistic actions: the BeneMin RCT
by: Bill Deakin, et al.
Published: (2019-08-01) -
Minocycline, focus on mechanisms of resistance, antibacterial activity, and clinical effectiveness: Back to the future
by: Arezoo Asadi, et al.
Published: (2020-09-01) -
Pigmentary and Other Dermatologic Manifestations of Minocycline: a reminder of adverse effects
by: Kayla Rodriguez, et al.
Published: (2019-10-01)